
Corteva (CTVA): Earnings Recovery Meets Separation Risk
Corteva’s earnings are improving, with 1H 2026 sales, EBITDA, and EPS all rising, but valuation and the planned 2026 separation keep the setup balanced. The stock looks attractive for moderate-risk investors if execution stays on track.



